Show simple item record

dc.contributor.authorProvan, Den_US
dc.contributor.authorNewland, ACen_US
dc.date.accessioned2016-01-06T15:57:24Z
dc.date.issued2015-10en_US
dc.date.submitted2015-11-04T15:40:47.723Z
dc.identifier.issn0741-238Xen_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/10350
dc.descriptionThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International Licenseen_US
dc.format.extent875 - 887en_US
dc.language.isoenen_US
dc.relation.ispartofADVANCES IN THERAPYen_US
dc.subjectEltrombopagen_US
dc.subjectImmune thrombocytopeniaen_US
dc.subjectITPen_US
dc.subjectManagementen_US
dc.subjectRomiplostimen_US
dc.subjectSecond-line therapyen_US
dc.subjectSustained responsesen_US
dc.subjectTPO receptor agonistsen_US
dc.titleCurrent Management of Primary Immune Thrombocytopeniaen_US
dc.typeArticle
dc.rights.holder2015. The authors
dc.rights.holder2015. The authors
dc.identifier.doi10.1007/s12325-015-0251-zen_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365796200001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue10en_US
pubs.notesNot knownen_US
pubs.organisational-group/Queen Mary University of London
pubs.organisational-group/Queen Mary University of London/Faculty of Medicine & Dentistry
pubs.organisational-group/Queen Mary University of London/Faculty of Medicine & Dentistry/Blizard Institute
pubs.organisational-group/Queen Mary University of London/Faculty of Medicine & Dentistry/Blizard Institute/Immunobiology
pubs.organisational-group/Queen Mary University of London/REF
pubs.organisational-group/Queen Mary University of London/REF/REF - SMD - Blizard
pubs.publication-statusPublisheden_US
pubs.volume32en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record